21/11/2022Published by Fondazione Gianni Bonadonna at 21/11/2022Categories Events UncategorizedHow to select patients with breast and ovarian cancer for the treatment with olaparib
14/11/2022Published by Fondazione Gianni Bonadonna at 14/11/2022Categories Events UncategorizedTalazoparib as monotherapy in advanced breast cancer
09/11/2022Published by Fondazione Gianni Bonadonna at 09/11/2022Categories Events UncategorizedOlaparib shows promising results in early breast cancer
31/10/2022Published by Fondazione Gianni Bonadonna at 31/10/2022Categories Events UncategorizedTrastuzumab deruxtecan in HER2+ breast cancer with brain metastases
24/10/2022Published by Fondazione Gianni Bonadonna at 24/10/2022Categories Events UncategorizedClinical benefits of an early therapeutic targeting of ESR1 mutation
17/10/2022Published by Fondazione Gianni Bonadonna at 17/10/2022Categories Events UncategorizedTreatment selection with genomics for metastatic breast cancer
10/10/2022Published by Fondazione Gianni Bonadonna at 10/10/2022Categories Events UncategorizedPembrolizumab as post-nephrectomy adjuvant therapy in renal cell carcinoma
03/10/2022Published by Fondazione Gianni Bonadonna at 03/10/2022Categories Events UncategorizedNeoadjuvant immunotherapy as a promising approach in melanoma and colon cancer
26/09/2022Published by Fondazione Gianni Bonadonna at 26/09/2022Categories Events UncategorizedBenefits of pralsetinib in patients with RET fusions
